In a new study published in Neuron, researchers at the Tata Institute of Fundamental Research in India uncovered how the little-known psychedelic drug DOI (2,5-dimethoxy-4-iodoamphetamine) can reduce ...
Drug companies recommend anti-anxiety pills. TV ads promulgate pills ... Twenty years ago, physician Russell Portenoy, a prominent New York pain specialist, spearheaded the movement that ...
Evidence has been growing to suggest that tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, poses risks to the developing fetus by impacting brain development. Now a new ...
A new study using mouse models indicates it may ... Although DOI is not under clinical investigation as a therapeutic drug, this study underscores the importance of understanding psychedelics' basic ...